Q1 2024 Holdings
Filed 2024-05-03 | 7 holdings | $103.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $34.0M | 498,558 | 32.9% |
| Skye Bioscience, Inc.(SKYE) | Common Stock | 83086J200 | $31.4M | 2,007,702 | 30.4% |
| Repare Therapeutics, Inc.(RPTX) | Common Stock | 760273102 | $12.5M | 2,646,657 | 12.1% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $9.2M | 3,561,150 | 8.9% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $7.2M | 506,822 | 6.9% |
| Passage Bio, Inc. | Common Stock | 702712100 | $6.7M | 4,959,769 | 6.5% |
| Aligos Therapeutics, Inc. | Common Stock | 01626L105 | $2.3M | 2,320,381 | 2.2% |